{"id":446273,"title":"Changes to notification requirements for biologic drugs: Notice to industry - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T11:34:05.058000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/notice-notification-requirements-biologic-drugs.html?wbdisable=false","snippet":"Changes to notification requirements for biologic drugs: Notice to industry Health Canada is reducing the administrative burden to help clinical trial sponsors and market authorization holders efficiently distribute treatments. On this page Purpose and background Measures to…","rawSnapshotUrl":"/api/snapshots/raw/446273","browseUrl":"https://replay.healtharchive.ca/job-6/20260103113405/https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/notice-notification-requirements-biologic-drugs.html?wbdisable=false#ha_snapshot=446273","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}